MBX Biosciences, Inc. (MBX) vs Zai Lab Limited Unsponsored ADR (ZLAB)
MBX Biosciences, Inc. and Zai Lab Limited Unsponsored ADR are both Biotechnology companies. MBX Biosciences, Inc. and Zai Lab Limited Unsponsored ADR are of similar size ($2.9B and $2.7B). MBX Biosciences, Inc. has the higher net margin (0.00% vs −41.9%) and the higher return on invested capital (0.00% vs −129.3%). Across the 13 metrics below, MBX Biosciences, Inc. leads on 9 and Zai Lab Limited Unsponsored ADR on 4.
Valuation
Profitability
| Metric | MBX | ZLAB | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 56.47% | 65.16% |
| Operating margin | 0.00% | (58.74%) | 0.00% |
| Net margin | 0.00% | (41.86%) | 0.00% |
| Free cash flow margin | 0.00% | (36.13%) | 0.00% |
| Return on equity | (33.17%) | (26.91%) | (57.72%) |
| Return on assets | (31.25%) | (16.81%) | (49.22%) |
| Return on invested capital | 0.00% | (129.34%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack